Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹200 | - |
Expense Ratio | 2.45 | - |
NAV | ₹29.32 | - |
Fund Started | 08 Feb 2019 | - |
Fund Size | ₹86.00 Cr | - |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹200
-
Expense Ratio
2.45
-
NAV
₹29.32
-
Fund Started
08 Feb 2019
-
Fund Size
₹86.00 Cr
-
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
-
1 Year | -4.26% | - |
3 Year | 20.59% | - |
5 Year | 11.69% | - |
1 Year
-4.26%
-
3 Year
20.59%
-
5 Year
11.69%
-
Equity | 98.46% | - |
Cash | 1.54% | - |
Equity
98.46%
-
Cash
1.54%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.47% |
Apollo Hospitals Enterprise Ltd. | 5.73% |
Torrent Pharmaceuticals Ltd. | 5.68% |
Cipla Ltd. | 5.56% |
Neuland Laboratories Ltd. | 4.85% |
Divi's Laboratories Ltd. | 4.64% |
Fortis Healthcare Ltd. | 4.50% |
Aurobindo Pharma Ltd. | 4.46% |
Piramal Pharma Ltd. | 4.32% |
Alkem Laboratories Ltd. | 3.41% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | - |
Launch Date | 08 Feb 2019 | - |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
-
Launch Date
08 Feb 2019
-